Introduction: Signet ring cell carcinoma is a rare tumor that generally originates in the gastrointestinal tract. Signet-ring cell carcinoma of the ampulla of Vater is extremely uncommon and a very rare clinical entity, which is infrequently reported in medical literature and only 31 cases have been mentioned. Most tumors affecting Vater’s Ampulla are adenocarcinomas and other histological variants are less frequent. It mainly occurs in elderly patients. Case Presentation: We report a case of signet ring cell carcinoma of Vater’s Ampulla. The tumour had infiltrated the duodenal, but local lymph nodes were clear (T3N0M0). Duodenopancreatectomy with pylorus preservation is the treatment of choice. Conclusions: Etiology and survival are not well-defined in the literature due to the extreme rarity of this disease.
Signet ring cell carcinoma (SRCC) is more commonly found in the stomach than at other sites in the digestive system. Malignant tumors of Vater’s Ampulla are usually well-differentiated adenocarcinomas, and the signet ring cell variant of ampullary adenocarcinoma is rare [
We report the case of a 57-year-old man, admitted with jaundice, abdominal pain four months ago and 10 kg weight loss. Abdominal ultrasound showed dilatation of the common bile duct and the intrahepatic bile ducts. No locoregional lymph nodes were observed. Abdominal computed tomography (
The final pathological examination confirmed an SRCC of the ampulla of Vater (Figures 2 and 3) and the duodenum were infiltrated with carcinoma. No distal or nodal metastases were identified and no evidence of lymphatic and vascular invasion. The ampullary cancer was classified as T3N0M0 and six cycles of adjuvant chemotherapy based on CISPLATIN + GEMCITABINE were performed with good clinical tolerance. There was no evidence of local tumor recurrence and metastatic on postoperative computed tomography scans during 10 months.
Adenocarcinoma of Vater’s ampulla is a rare clinical entity, occurring in less than six cases per million people annually [
SRCC can arise in many organs, but it usually occurs in the gastrointestinal tract, especially in the stomach. It has been reported that 90% of SRCC occurs in the stomach, with the rest arising in several other organs, including the breast, gallbladder, pancreas, urinary bladder and colon [
SRCC of Vater’s ampulla represents a variant of adenocarcinoma, characterised by the presence of greater than 50% signetring cells with intra-cytoplasmic mucin, and typically eccentrically-located crescent-shaped
nuclei [
Little is known about this tumor’s natural history and prognosis.
Histologically, the origin of signet-ring cells remains unknown, but the following hypotheses have been proposed by various investigators. One is that SRCC arises from ectopic gastric mucosa found in the duodenum [
In our case, there was no ectopic gastric mucosa found in the peritumoral mucosa, and the patient had no history of peptic ulcer disease.
33 cases of SRCC of Vater’s ampulla that have been reported in the literature.
Metesh [
Akatsu [
Hara [
For the diagnosis of SRCC, helical computed tomography (CT) showes a dilated CBD (common bile duct) without a mass lesion in the ampulla of Vater in some cases [
Contrast-enhanced ultrasound (CEUS) has gained increasing interest in recent years and may provide an effective means of diagnosis of ampullary carcinomas. The lesion may be displayed much clearer than by conventional gray-scale ultrasound and it can also offer a good method in the discrimination of ampullary carcinoma from non-malignant lesions [
The majority of patients in previous cases of ampullary SRCC underwent pancreaticoduodenectomy, occasionally with extended lymphadenectomy and/or partial gastrectomy. This radical approach facilitates lymph node dissection in advanced disease, but a pylorus-preserving technique, which has been utilised in three previous cases of ampullary SRCC [
In our case, the preoperative diagnosis was an advanced tumor with invasion of the duodenum wall, so a pancreaticoduodenectomy and extended lymphadenectomy were performed.
Our patient had the typical characteristics of other cases in terms of age, jaundice, macroscopic appearance. Abdominal computed tomography showed a tumor in the ampulla of Vater with invasion of D3 and a dilatation of the extra hepatic bile duct and the same treatment approach, and TNM classification.
Adjuvant chemotherapy may be appropriate in the treatment of ampullary SRCC associated with locoregional metastasis. However, its role in node-negative and distant metastatic disease remains as yet undetermined and, from the case reports evaluated, consensus regarding the optimum chemotherapeutic regimen is lacking [
SRCC localized in other digestive organs have a poor prognosis.
The experience from previously reported cases of carcinoma of the ampulla of Vater suggests a good prognosis, provided there is no metastasis at the time of surgery [
Duodenopancreatectomy with pylorus preservation is the treatment of choice in ampullar cancers [
We report a very rare case of SRCC of the ampullary of vater with invasion of the duodenum without lymphom node infiltration or distant metastatic disease.
Pancreaticoduodenectomy is the treatment of choice for localized disease.
Although several cases have been reported, the detailed clinicopathological features and prognosis are not clear.
More case reports are needed to establish the role of adjuvant chemotherapy in this tumor.